{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T01:47:57Z","timestamp":1773798477955,"version":"3.50.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":3293,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1038\/sj.ki.5001997","type":"journal-article","created":{"date-parts":[[2006,11,30]],"date-time":"2006-11-30T09:20:30Z","timestamp":1164878430000},"page":"S10-S15","source":"Crossref","is-referenced-by-count":33,"special_numbering":"S105","title":["A new era in phosphate binder therapy: What are the options?"],"prefix":"10.1016","volume":"70","author":[{"given":"I.B.","family":"Salusky","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/sj.ki.5001997_bb0010","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1517\/14656566.4.6.941","article-title":"Phosphate binder usage in kidney failure patients","volume":"4","author":"Bleyer","year":"2003","journal-title":"Expert Opin Pharmacother"},{"issue":"Suppl 90","key":"10.1038\/sj.ki.5001997_bb0015","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1111\/j.1523-1755.2004.09005.x","article-title":"A comparison of clinically useful phosphorus binders for patients with chronic kidney failure","volume":"66","author":"Emmett","year":"2004","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001997_bb0020","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1093\/ndt\/14.12.2835","article-title":"Nocturnal home haemodialysis: an update on a 5-year experience","volume":"14","author":"Pierratos","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/sj.ki.5001997_bb0025","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1542-4758.2006.00109.x","article-title":"Calcium phosphate metabolism and bone mineral density with nocturnal hemodialysis","volume":"10","author":"Toussaint","year":"2006","journal-title":"Hemodial Int"},{"issue":"Suppl 1","key":"10.1038\/sj.ki.5001997_bb0030","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000083712","article-title":"Accumulation of metals and minerals from phosphate binders","volume":"23","author":"Molony","year":"2005","journal-title":"Blood Purif"},{"issue":"Suppl 2","key":"10.1038\/sj.ki.5001997_bb0035","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/ndt\/17.suppl_2.9","article-title":"The clinical impact of aluminium overload in renal failure","volume":"17","author":"Cannata-And\u00eda","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/sj.ki.5001997_bb0040","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1600-0773.1990.tb00692.x","article-title":"Aluminium toxicokinetics","volume":"66","author":"Wilhelm","year":"1990","journal-title":"Pharmacol Toxicol"},{"key":"10.1038\/sj.ki.5001997_bb0045","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1056\/NEJM199102213240804","article-title":"Aluminum accumulation during treatment with aluminium hydroxide and dialysis in children and young adults with chronic renal disease","volume":"324","author":"Salusky","year":"1991","journal-title":"N Engl J Med"},{"issue":"Suppl 3","key":"10.1038\/sj.ki.5001997_bb0050","first-page":"S12","article-title":"K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease","volume":"42","author":"National Kidney Foundation","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5001997_bb0055","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/ki.1989.286","article-title":"Citrate: a major factor in the toxicity of orally administered aluminum compounds","volume":"36","author":"Molitoris","year":"1989","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001997_bb0060","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S0272-6386(12)80356-8","article-title":"Calcium citrate markedly enhances aluminum absorption from aluminum hydroxide","volume":"17","author":"Coburn","year":"1991","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5001997_bb0065","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJM198607173150304","article-title":"Calcium carbonate as a phosphate binder in patients with chronic renal failure undergoing dialysis","volume":"315","author":"Slatopolsky","year":"1986","journal-title":"N Engl J Med"},{"issue":"Part 1","key":"10.1038\/sj.ki.5001997_bb0070","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0022-3476(86)81064-2","article-title":"Effects of oral calcium carbonate on control of serum phosphorus and changes in plasma aluminum levels after discontinuation of aluminum-containing gels in children receiving dialysis","volume":"108","author":"Salusky","year":"1986","journal-title":"J Pediatr"},{"key":"10.1038\/sj.ki.5001997_bb0075","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1681\/ASN.2005060663","article-title":"Control of hyperphosphatemia among patients with ESRD","volume":"16","author":"Coladonato","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5001997_bb0080","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1172\/JCI113886","article-title":"Reduction of dietary phosphorus absorption by phosphorus binders. A theoretical in vitro and in vivo study","volume":"83","author":"Sheikh","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1038\/sj.ki.5001997_bb0085","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1681\/ASN.V1291978","article-title":"Adynamic renal osteodystrophy: is there a problem?","volume":"12","author":"Salusky","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5001997_bb0090","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/ki.1994.342","article-title":"Evidence for abnormal calcium homeostasis in patients with adynamic bone disease","volume":"46","author":"Kurz","year":"1994","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001997_bb0095","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJM200005183422003","article-title":"Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis","volume":"342","author":"Goodman","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1038\/sj.ki.5001997_bb0100","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1093\/ndt\/15.7.1014","article-title":"Arterial stiffening and vascular calcifications in end-stage renal disease","volume":"15","author":"Gu\u00e9rin","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/sj.ki.5001997_bb0105","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1161\/01.CIR.0000020222.63035.C0","article-title":"Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure","volume":"106","author":"Oh","year":"2002","journal-title":"Circulation"},{"key":"10.1038\/sj.ki.5001997_bb0110","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1093\/ndt\/gfg414","article-title":"Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality","volume":"18","author":"London","year":"2003","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl 1","key":"10.1038\/sj.ki.5001997_bb0115","first-page":"5","article-title":"Aluminum and renal osteodystrophy","volume":"6","author":"Sherrard","year":"1986","journal-title":"Semin Nephrol"},{"key":"10.1038\/sj.ki.5001997_bb0120","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/ki.1988.96","article-title":"Bone disease in pediatric patients undergoing dialysis with CAPD or CCPD","volume":"33","author":"Salusky","year":"1988","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001997_bb0125","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000185718","article-title":"Disappearance of aluminic bone disease in a long term asymptomatic dialysis population restricting A1(OH)3 intake: emergence of an idiopathic adynamic bone disease not related to aluminum","volume":"53","author":"Moriniere","year":"1989","journal-title":"Nephron"},{"issue":"Suppl","key":"10.1038\/sj.ki.5001997_bb0130","first-page":"S62","article-title":"Risk of adynamic bone disease in dialyzed patients","volume":"38","author":"Malluche","year":"1992","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001997_bb0135","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ki.1993.64","article-title":"The spectrum of bone disease in end-stage renal failure \u2013 an evolving disorder","volume":"43","author":"Sherrard","year":"1993","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001997_bb0140","first-page":"270A","article-title":"No evidence of osteomalacia in dialysis patients treated with lanthanum carbonate up to 5 years","volume":"15","author":"Malluche","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5001997_bb0145","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1097\/01.ASN.0000129337.50739.48","article-title":"Arterial calcifications and bone histomorphometry in end-stage renal disease","volume":"15","author":"London","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5001997_bb0150","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1159\/000182446","article-title":"The use of magnesium-containing phosphate binders in patients with end-stage renal disease on maintenance hemodialysis","volume":"30","author":"Guillot","year":"1982","journal-title":"Nephron"},{"key":"10.1038\/sj.ki.5001997_bb0155","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/oxfordjournals.ndt.a091722","article-title":"Magnesium hydroxide as a complementary aluminium-free phosphate binder to moderate doses of oral calcium in uraemic patients on chronic haemodialysis: lack of deleterious effect on bone mineralisation","volume":"3","author":"Morini\u00e8re","year":"1988","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/sj.ki.5001997_bb0160","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/ki.1996.22","article-title":"Magnesium carbonate as a phosphorus binder: a prospective, controlled, crossover study","volume":"49","author":"Delmez","year":"1996","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001997_bb0165","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.1523-1755.2002.00434.x","article-title":"Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients","volume":"62","author":"Chertow","year":"2002","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001997_bb0170","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1111\/j.1523-1755.2005.00600.x","article-title":"Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis","volume":"68","author":"Block","year":"2005","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001997_bb0175","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/S0272-6386(99)70221-0","article-title":"A comparison of the calcium-free phosphate binder sevelamer hydrochloride with calcium acetate in the treatment of hyperphosphatemia in hemodialysis patients","volume":"33","author":"Bleyer","year":"1999","journal-title":"Am J Kid Dis"},{"key":"10.1038\/sj.ki.5001997_bb0180","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1093\/ndt\/14.12.2907","article-title":"Long-term effects of sevelamer hydrochloride on the calcium \u00d7 phosphate product and lipid profile of haemodialysis patients","volume":"14","author":"Chertow","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/sj.ki.5001997_bb0185","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1053\/jarr.2003.50016","article-title":"Meta-analysis of the effect of sevelamer on phosphorus, calcium, PTH, and serum lipids in dialysis patients","volume":"10","author":"Burke","year":"2003","journal-title":"Adv Ren Replace Ther"},{"key":"10.1038\/sj.ki.5001997_bb0190","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1111\/j.1523-1755.2004.00590.x","article-title":"Treatment of hyperphosphatemia in hemodialysis patients: the Calcium Acetate Renagel Evaluation (CARE study)","volume":"65","author":"Qunibi","year":"2004","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001997_bb0195","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1681\/ASN.2004100885","article-title":"Sevelamer controls parathyroid hormone-induced bone disease as efficiently as calcium carbonate without increasing serum calcium levels during therapy with active vitamin D sterols","volume":"16","author":"Salusky","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5001997_bb0200","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1359\/JBMR.041221","article-title":"Decrease in thoracic vertebral bone attenuation with calcium-based phosphate binders in hemodialysis","volume":"20","author":"Raggi","year":"2005","journal-title":"J Bone Miner Res"},{"issue":"suppl","key":"10.1038\/sj.ki.5001997_bb0205","first-page":"S5","article-title":"Pleiotropic effects of the non-calcium phosphate binder sevelamer","volume":"70","author":"Nikolov","year":"2006","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001997_bb0210","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.ahj.2004.07.023","article-title":"Potential antiatherogenic and anti-inflammatory properties of sevelamer in maintenance hemodialysis patients","volume":"149","author":"Ferramosca","year":"2005","journal-title":"Am Heart J"},{"key":"10.1038\/sj.ki.5001997_bb0215","first-page":"381","article-title":"Simultaneous lowering of serum phosphate and LDL-cholesterol by sevelamer hydrochloride (RenaGel) in dialysis patients","volume":"50","author":"Wilkes","year":"1998","journal-title":"Clin Nephrol"},{"key":"10.1038\/sj.ki.5001997_bb0220","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1081\/JDI-65259","article-title":"Effect of sevelamer on dyslipidemia and chronic inflammation in maintenance hemodialysis patients","volume":"27","author":"Yamada","year":"2005","journal-title":"Ren Fail"},{"issue":"Suppl 85","key":"10.1038\/sj.ki.5001997_bb0225","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1046\/j.1523-1755.63.s85.18.x","article-title":"A multicenter study on the effects of lanthanum carbonate (Fosrenol\u2122) and calcium carbonate on renal bone disease in dialysis patients","volume":"63","author":"D'Haese","year":"2003","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001997_bb0230","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000084653","article-title":"Efficacy, tolerability and safety of lanthanum carbonate in hyperphosphatemia: a 6-month, randomized, comparative trial versus calcium carbonate","volume":"100","author":"Hutchison","year":"2005","journal-title":"Nephron Clin Pract"},{"key":"10.1038\/sj.ki.5001997_bb0235","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0272-6386(03)00554-7","article-title":"Randomized, double-blind, placebo-controlled, dose-titration, phase III study assessing the efficacy and tolerability of lanthanum carbonate: a new phosphate binder for the treatment of hyperphosphatemia","volume":"42","author":"Joy","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5001997_bb0240","doi-asserted-by":"crossref","first-page":"193","DOI":"10.5414\/CNP62193","article-title":"Efficacy and safety of lanthanum carbonate for reduction of serum phosphorus in patients with chronic renal failure receiving hemodialysis","volume":"62","author":"Finn","year":"2004","journal-title":"Clin Nephrol"},{"key":"10.1038\/sj.ki.5001997_bb0245","first-page":"272A","article-title":"Lanthanum accumulation in rats with adenine-induced chronic renal failure","volume":"15","author":"Berlove","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5001997_bb0250","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/j.1523-1755.2005.00171.x","article-title":"Chronic renal failure is associated with increased tissue deposition of lanthanum after 28-day oral administration","volume":"67","author":"Lacour","year":"2005","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001997_bb0255","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1111\/j.1523-1755.2005.00753.x","article-title":"Progressive accumulation of lanthanum in the liver of normal and uremic rats","volume":"68","author":"Slatopolsky","year":"2005","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001997_bb0260","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1093\/ndt\/gfl146","article-title":"Evolution of bone and plasma concentration of lanthanum in dialysis patients before, during 1 year of treatment with lanthanum carbonate and after 2 years of follow-up","volume":"21","author":"Spasovski","year":"2006","journal-title":"Nephrol Dial Transplant."}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815518668?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815518668?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T08:38:02Z","timestamp":1628152682000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815518668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":51,"alternative-id":["S0085253815518668"],"URL":"https:\/\/doi.org\/10.1038\/sj.ki.5001997","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2006,12]]}}}